EUVIMEDEUVIMED entdecken
Crossref

Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody

Yumi Yamashita, Fumie Abe, Rei Hirochika, Satoko Tahara-Hanaoka, Akira Shibuya, Kazuko Shibuya

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2013

DOI: 10.1089/mab.2012.0083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2013. Verfasst von Yumi Yamashita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Division of Biomedical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNAM-1 (CD226) is expressed on the majority of NK cells, CD8 + T cells, and CD4 + T cells and mediates an activating signal in these cells upon binding to the ligands CD155 or CD112 expressed on target cells or antigen-presenting cells. DNAM-1 plays an important role in tumor immunity mediated by NK cells and CD8 + T cells and the development of graft-versus-host disease (GVHD) in mice. We previously generated a monoclonal antibody against mouse DNAM-1, TX42, which inhibited DNAM-1 binding to its ligands CD155 and CD112 and inhibited activation of NK cells and CD8 + T cells in vitro . Injection of mice with TX42 ameliorated the development of GVHD in mice. Here, we generated a new clone of anti-DNAM-1 MAb, TX92. TX92 similarly stained primary spleen cells, including CD8 + and CD4 + T cells and NK cells. TX92 as well as TX42 interfered with the interaction between DNAM-1 and ligands CD155 and CD112. However, TX92 recognizes a different epitope and, unlike TX42 partially, but not completely, depleted peripheral blood (PB) CD8 + T cells in vivo . Thus, TX92 is a unique MAb that is characterized not only by inhibitory function of DNAM-1 binding to the ligands but also by function of partial depletion of PB CD8 + T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntibodies, MonoclonalAntigens, Differentiation, T-LymphocyteCD8-Positive T-LymphocytesDNA PrimersGraft vs Host DiseaseInterferon-gammaKiller Cells, NaturalLymphocyte DepletionMiceMice, Inbred BALB CMice, Inbred C57BLT-LymphocytesT Lineage-Specific Activation Antigen 1

Substanzen

Antibodies, MonoclonalAntigens, Differentiation, T-LymphocyteT Lineage-Specific Activation Antigen 1DNA PrimersInterferon-gamma

Autor:innen und Institutionen

  • Department of Immunology, Division of Biomedical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Zitieren

APA

Yamashita, Y., Abe, F., Hirochika, R., Tahara-Hanaoka, S., Shibuya, A., & Shibuya, K. (2013). Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2012.0083

Vancouver

Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K. Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2013. doi:10.1089/mab.2012.0083

BibTeX
@article{Yamashita2013,
  author = {Yamashita, Yumi and Abe, Fumie and Hirochika, Rei and Tahara-Hanaoka, Satoko and Shibuya, Akira and Shibuya, Kazuko},
  title = {Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody},
  journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
  year = {2013},
  doi = {10.1089/mab.2012.0083}
}
Kostenlos starten →